Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (7373)	11/13/1997 2:26:00 AM
From: milton	Respond to of 14328

Scott Davis Thanks for your cogent comments. I agree that triby's fundamentals are not driving its price right now. A recent post by Stitts went to the mark in that a stock is not over or under valued-- its value is what people are willing to pay for it. At this point, triby is ahead of the crowd. The rest of the bio market is languishing and there are dog bio stocks trading at higher multiples with lower forward pe's than triby. If triby keeps up its phenomenal earnings growth, our patience will be more than rewarded. I feel that the Nov 28 warrant exp. date will lift the $3 lid on triby. The next milestone is the dec 31 financial report. We will finally have disclosed the amount of b shares to be exercised at $4 in 1998. If that number is a small multiple of the 18 million shares outstanding, then its effect on the overall triby price will be ignored. I believe we are looking at a $10 stock in the next 9 months. $20 is not out of reason in the next 18 to 24 months provided triby holds true to form. PS For the warrant situation, see biz.yahoo.com . Stay long as this one will be a winner.